SynthesisInternational urology and nephrology2022

Effectiveness of fibroblast growth factor 23 lowering modalities in chronic kidney disease: a systematic review and meta-analysis.

Kullaya Takkavatakarn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.